Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
EV to Sales HistoryFair Value
Percentile Rank14
3Y CAGR-3.9%
5Y CAGR-1.9%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-3.9%/yr
vs +0.2%/yr prior
5Y CAGR
-1.9%/yr
Consistent
Acceleration
-4.1pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.60 | +3.2% |
| 2024 | 5.43 | -24.0% |
| 2023 | 7.14 | +13.1% |
| 2022 | 6.31 | +52.5% |
| 2021 | 4.14 | -32.9% |
| 2020 | 6.18 | +1.0% |
| 2019 | 6.11 | -2.6% |
| 2018 | 6.28 | -15.2% |
| 2017 | 7.40 | -15.6% |
| 2016 | 8.77 | - |